Vaxil Bio (TSXV:VXL) Operating Cash Flow per Share : C$-0.00 (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Operating Cash Flow per Share?

Vaxil Bio's operating cash flow per share for the three months ended in Dec. 2023 was C$-0.00. Vaxil Bio's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 30.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 29.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Vaxil Bio's Operating Cash Flow per Share or its related term are showing as below:

TSXV:VXL' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 10.1 Med: 39.5 Max: 63.3
Current: 30.7

During the past 13 years, Vaxil Bio's highest 3-Year average Operating Cash Flow per Share Growth Rate was 63.30% per year. The lowest was 10.10% per year. And the median was 39.50% per year.

TSXV:VXL's 3-Year OCF Growth Rate is ranked better than
80.32% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs TSXV:VXL: 30.70

Vaxil Bio Operating Cash Flow per Share Historical Data

The historical data trend for Vaxil Bio's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Operating Cash Flow per Share Chart

Vaxil Bio Annual Data

Trend

May14

May15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.01

Vaxil Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Vaxil Bio's Operating Cash Flow per Share

For the Biotechnology subindustry, Vaxil Bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaxil Bio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's Price-to-Operating-Cash-Flow falls into.

Vaxil Bio Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Vaxil Bio's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-0.561	/	136.979
	=	-0.00

Vaxil Bio's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-0.069	/	136.979
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00

Vaxil Bio Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxil Bio (TSXV:VXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

VXLLF:USA

Address

C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.vaxil-bio.com

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Executives

Gadi Levin

Director, Senior Officer

Vaxil Bio (TSXV:VXL) Headlines

No Headlines